The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Heikki Joensuu

Department of Oncology

Helsinki University Central Hospital

Haartmaninkatu 4

POB 180

Finland

[email]@hus.fi

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Oncology, Helsinki University Central Hospital, Haartmaninkatu 4, POB 180, Finland. 2000 - 2012

References

  1. Adjuvant treatment of GIST: patient selection and treatment strategies. Joensuu, H. Nat. Rev. Clin. Oncol (2012) [Pubmed]
  2. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial. Joensuu, H., Kellokumpu-Lehtinen, P.L., Huovinen, R., Jukkola-Vuorinen, A., Tanner, M., Kokko, R., Ahlgren, J., Auvinen, P., Paija, O., Helle, L., Villman, K., Nyandoto, P., Nilsson, G., Pajunen, M., Asola, R., Poikonen, P., Leinonen, M., Kataja, V., Bono, P., Lindman, H. J. Clin. Oncol. (2012) [Pubmed]
  3. The management of gastrointestinal stromal tumors: a model for targeted and multidisciplinary therapy of malignancy. Joensuu, H., Dematteo, R.P. Annu. Rev. Med. (2012) [Pubmed]
  4. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. Joensuu, H., Eriksson, M., Sundby Hall, K., Hartmann, J.T., Pink, D., Schütte, J., Ramadori, G., Hohenberger, P., Duyster, J., Al-Batran, S.E., Schlemmer, M., Bauer, S., Wardelmann, E., Sarlomo-Rikala, M., Nilsson, B., Sihto, H., Monge, O.R., Bono, P., Kallio, R., Vehtari, A., Leinonen, M., Alvegård, T., Reichardt, P. JAMA (2012) [Pubmed]
  5. Practical management of tyrosine kinase inhibitor-associated side effects in GIST. Joensuu, H., Trent, J.C., Reichardt, P. Cancer Treat. Rev. (2011) [Pubmed]
  6. Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial. Joensuu, H., Sailas, L., Alanko, T., Sunela, K., Huuhtanen, R., Utriainen, M., Kokko, R., Bono, P., Wigren, T., Pyrhönen, S., Turpeenniemi-Hujanen, T., Asola, R., Leinonen, M., Hahka-Kemppinen, M., Kellokumpu-Lehtinen, P. Ann. Oncol. (2010) [Pubmed]
  7. Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial. Joensuu, H., Bono, P., Kataja, V., Alanko, T., Kokko, R., Asola, R., Utriainen, T., Turpeenniemi-Hujanen, T., Jyrkkiö, S., Möykkynen, K., Helle, L., Ingalsuo, S., Pajunen, M., Huusko, M., Salminen, T., Auvinen, P., Leinonen, H., Leinonen, M., Isola, J., Kellokumpu-Lehtinen, P.L. J. Clin. Oncol. (2009) [Pubmed]
  8. Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial. Joensuu, H., Kellokumpu-Lehtinen, P.L., Huovinen, R., Jukkola-Vuorinen, A., Tanner, M., Asola, R., Kokko, R., Ahlgren, J., Auvinen, P., Hemminki, A., Paija, O., Helle, L., Nuortio, L., Villman, K., Nilsson, G., Lahtela, S.L., Lehtiö, K., Pajunen, M., Poikonen, P., Nyandoto, P., Kataja, V., Bono, P., Leinonen, M., Lindman, H. Lancet Oncol. (2009) [Pubmed]
  9. Systemic chemotherapy for cancer: from weapon to treatment. Joensuu, H. Lancet Oncol. (2008) [Pubmed]
  10. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Joensuu, H. Hum. Pathol. (2008) [Pubmed]
  11. Cardiac toxicity of sunitinib. Joensuu, H. Lancet (2007) [Pubmed]
  12. Second line therapies for the treatment of gastrointestinal stromal tumor. Joensuu, H. Curr. Opin. Oncol (2007) [Pubmed]
  13. Sunitinib for imatinib-resistant GIST. Joensuu, H. Lancet (2006) [Pubmed]
  14. Aromatase inhibitors in the treatment of early and advanced breast cancer. Joensuu, H., Ejlertsen, B., Lønning, P.E., Rutqvist, L.E. Acta. Oncol (2005) [Pubmed]
  15. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. Joensuu, H., Puputti, M., Sihto, H., Tynninen, O., Nupponen, N.N. J. Pathol. (2005) [Pubmed]
  16. Gastrointestinal stromal tumors--a review. Joensuu, H., Kindblom, L.G. Acta. Orthop. Scand. Suppl (2004) [Pubmed]
  17. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. Joensuu, H., Lehtimäki, T., Holli, K., Elomaa, L., Turpeenniemi-Hujanen, T., Kataja, V., Anttila, A., Lundin, M., Isola, J., Lundin, J. JAMA (2004) [Pubmed]
  18. Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study. Joensuu, H., Isola, J., Lundin, M., Salminen, T., Holli, K., Kataja, V., Pylkkänen, L., Turpeenniemi-Hujanen, T., von Smitten, K., Lundin, J. Clin. Cancer Res. (2003) [Pubmed]
  19. Boron neutron capture therapy of brain tumors: clinical trials at the finnish facility using boronophenylalanine. Joensuu, H., Kankaanranta, L., Seppälä, T., Auterinen, I., Kallio, M., Kulvik, M., Laakso, J., Vähätalo, J., Kortesniemi, M., Kotiluoto, P., Serén, T., Karila, J., Brander, A., Järviluoma, E., Ryynänen, P., Paetau, A., Ruokonen, I., Minn, H., Tenhunen, M., Jääskeläinen, J., Färkkilä, M., Savolainen, S. J. Neurooncol. (2003) [Pubmed]
  20. Treatment of inoperable gastrointestinal stromal tumor (GIST) with Imatinib (Glivec, Gleevec). Joensuu, H. Med. Klin. (Munich) (2002) [Pubmed]
  21. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. Joensuu, H., Anttonen, A., Eriksson, M., Mäkitaro, R., Alfthan, H., Kinnula, V., Leppä, S. Cancer Res. (2002) [Pubmed]
  22. Management of malignant gastrointestinal stromal tumours. Joensuu, H., Fletcher, C., Dimitrijevic, S., Silberman, S., Roberts, P., Demetri, G. Lancet Oncol. (2002) [Pubmed]
  23. Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer. Joensuu, H., Holli, K., Oksanen, H., Valavaara, R. Breast Cancer Res. Treat. (2000) [Pubmed]
 
WikiGenes - Universities